Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for individuals suffering from relapsed or refractory T-cell acute lymphoblastic leukemia. BEAM-301 is a liver-targeted candidate aimed at patients afflicted with Glycogen Storage Disease Type Ia. Beyond these flagship programs, Beam Therapeutics is also engaged in devising treatments for alpha-1 antitrypsin deficiency, various ocular conditions, and other disorders impacting the liver, muscular system, and central nervous system. To further its research and development objectives, Beam Therapeutics has forged numerous strategic alliances and partnerships. These include collaborations with Boston Children's Hospital; a research and clinical trial agreement with Magenta Therapeutics, Inc.; a licensing deal with Sana Biotechnology, Inc.; and a research partnership with the Institute of Molecular and Clinical Ophthalmology Basel. Additionally, the company maintains research collaborations with both Pfizer Inc. and Apellis Pharmaceuticals, Inc., alongside a comprehensive collaboration and license agreement with Verve Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Beam Therapeutics Inc.
NASDAQ:BEAMHealthcare · Biotechnology
-5.58%$27.23
AH$27.71+1.76%vs close
Mkt Cap$2.81B
Float81.98M
O/S103.29M
Vol
$ Vol
RVOL
Inst Own-
SI32.0%
Earnings
Dilution
Financials Summary
Revenue$139.74M
Net Income-$79.99M
Total Assets$1.48B
Free Cash Flow-$360.05M
Debt & Equity
Debt 19%
Equity 81%
Total Debt$293.88M
Total Equity$1.24B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in BEAM's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.48B
Liabilities$242.82M
Accounts Receivable$0
Accounts Payable$10.23M
Inventory$0
PP&E (Net)$205.18M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $139.74M | $63.52M | $377.71M | $60.92M | $51.84M | $24K | $18K | $0 | $0 |
| YoY Growth | 120.0% | -83.2% | 520.0% | 17.5% | 215916.7% | 33.3% | - | - | - |
| Cost of Revenue | $22.29M | $367.56M | $0 | $311.59M | $232.13M | $103.18M | $54.62M | $33.87M | $0 |
| Gross Profit | $117.45M | -$304.04M | $377.71M | -$250.67M | -$180.29M | -$103.16M | -$54.6M | -$33.87M | $0 |
| Gross Margin | 84.0% | -478.7% | 100.0% | -411.5% | -347.8% | -429812.5% | -303338.9% | - | - |
| Research and Development | $409.62M | $367.56M | $437.38M | $311.59M | $387.09M | $103.18M | $54.62M | $33.87M | $5.86M |
| Selling, General, and Administrative | $113.82M | $111.53M | $116.81M | $87.81M | $57.22M | $29.61M | $20.55M | $11.87M | $2.2M |
| Other | -$22.29M | -$367.56M | $0 | -$311.59M | -$232.13M | -$103.18M | -$54.62M | -$33.87M | $0 |
| Total Operating Expenses | $501.14M | $111.53M | $554.19M | $87.81M | $212.18M | $29.6M | $20.55M | $11.87M | $8.6M |
| Operating Income (EBIT) | -$383.69M | -$415.57M | -$176.49M | -$338.48M | -$392.46M | -$132.76M | -$75.15M | -$45.74M | -$8.6M |
| Operating Margin | -274.6% | -654.3% | -46.7% | -555.6% | -757.0% | -553166.7% | -417522.2% | - | - |
| Interest Expense | $43.73M | $0 | $0 | $0 | $0 | $0 | $187K | $0 | $0 |
| Interest Income | $0 | $49.09M | $46.68M | $15.3M | $0 | $1.57M | $2.49M | $292K | $0 |
| Other Income (Expense) | $303.7M | $38.87M | $45.32M | $52.8M | $21.83M | -$61.83M | -$3.17M | -$71M | -$133K |
| Income Before Tax (EBT) | -$79.99M | -$376.7M | -$131.16M | -$285.68M | -$370.64M | -$194.59M | -$78.33M | -$116.74M | -$8.73M |
| Income Tax Expense | $0 | $39K | $1.37M | $3.41M | $0 | $0 | $0 | $0 | $500K |
| Net Income | -$79.99M | -$376.74M | -$132.53M | -$289.09M | -$370.64M | -$194.59M | -$78.33M | -$115.26M | -$8.73M |
| Net Income Margin | -57.2% | -593.1% | -35.1% | -474.5% | -714.9% | -810800.0% | -435144.4% | - | - |
| Supplementary Data | |||||||||
| EPS | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 | -5.49 | -1.53 | -3.28 | -0.62 |
| Diluted EPS | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 | -5.49 | -1.53 | -3.28 | -0.62 |
| Weighted Average OS | 98.91M | 82.31M | 77.15M | 70.02M | 64.23M | 46.73M | 51.34M | 35.14M | 12.95M |
| EBITDA | -$13.96M | -$354.78M | -$111.15M | -$271.53M | -$230.06M | -$128.02M | -$71.65M | -$45.09M | -$8.59M |
| EBITDA Margin | -10.0% | -558.5% | -29.4% | -445.7% | -443.8% | -533437.5% | -398061.1% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $294.94M | $281.97M | $435.89M | $232.77M | $559.99M | $162.17M | $37.22M | $146.44M | $1.9M |
| Short-Term Investments | $950.27M | $568.77M | $753.98M | $845.37M | $405.65M | $137.5M | $54.63M | $0 | $0 |
| Cash and Short-Term Investments | $1.25B | $850.74M | $1.19B | $1.08B | $965.65M | $299.67M | $91.85M | $146.44M | $1.9M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $300M | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $27.41M | $21.17M | $14.76M | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $1.27B | $878.15M | $1.21B | $1.09B | $1.27B | $308.32M | $94.54M | $148.28M | $2.04M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $205.18M | $216.28M | $237.81M | $234.13M | $186.98M | $125.37M | $43.25M | $16.94M | $335K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $6.68M | $0 | $0 | $0 | $0 | $0 | $0 | $1.49M | $30K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $634K | $9.4M | $10.87M | $14.69M | $14.47M | $17.98M | $18.31M | $300K | $0 |
| Total Long-Term Assets | $212.49M | $225.68M | $248.67M | $248.82M | $201.45M | $143.36M | $61.55M | $18.74M | $365K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.48B | $1.1B | $1.46B | $1.34B | $1.47B | $451.68M | $156.1M | $167.01M | $2.4M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $10.23M | $3.87M | $1.62M | $9.03M | $7.47M | $6.31M | $7.85M | $7.35M | $726K |
| Short-Term Debt | $14.36M | $0 | $0 | $0 | $2.29M | $2.12M | $1.3M | $0 | $1.01M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $6.66M | $108.86M | $68.71M | $135.97M | $86.27M | $24K | $0 | $0 | -$1.01M |
| Other Current Liabilities | $36.34M | $19.74M | $100.69M | $49.68M | $60.83M | $83.02M | $12.56M | $16.54M | $4.7M |
| Total Current Liabilities | $96.94M | $182.07M | $205.56M | $223.59M | $213.44M | $102.34M | $29.14M | $25.59M | $6.57M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $139.76M | $0 | $0 | $0 | $3.01M | $5.29M | $4.41M | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $33.22M | $109.89M | $202.18M | $262.3M | $394K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$133.63M | $7.04M | $3.02M | $13.84M | $34.16M | $2.08M | $418K | $7.4M | $20K |
| Total Long-Term Liabilities | $145.88M | $188.21M | $272.82M | $384.64M | $434.28M | $103.78M | $26.02M | $7.4M | $20K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $242.82M | $370.28M | $478.38M | $608.24M | $647.72M | $206.12M | $55.15M | $32.98M | $6.58M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $302.05M | $251.43M | $5.26M |
| Common Stock | $1.02M | $836K | $816K | $712K | $684K | $573K | $73K | $56K | $5K |
| Retained Earnings | -$1.64B | -$1.57B | -$1.19B | -$1.06B | -$768.27M | -$397.64M | -$203.04M | -$124.72M | -$9.46M |
| Comprehensive Income & Other | $1.11M | $679K | $604K | -$2.43M | -$50K | -$9K | $16K | -$661K | -$11K |
| Other Stockholders' Equity | $2.88B | $2.3B | $2.17B | $1.79B | $1.59B | $642.62M | $303.92M | $258.69M | $5.27M |
| Total Equity | $1.24B | $733.54M | $981.33M | $733.47M | $826.74M | $245.56M | $100.94M | $134.03M | -$4.18M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.48B | $1.1B | $1.46B | $1.34B | $1.47B | $451.68M | $156.1M | $167.01M | $2.4M |
| Supplementary Data | |||||||||
| Total Debt | $293.88M | $161.43M | $172.69M | $179M | $147.64M | $107.64M | $31.24M | $0 | $1.01M |
| Net Debt | -$1.06M | -$120.54M | -$263.21M | -$53.76M | -$412.35M | -$54.53M | -$5.98M | -$146.44M | -$891K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$79.99M | -$376.74M | -$132.53M | -$289.09M | -$370.64M | -$194.59M | -$78.33M | -$116.74M | -$8M |
| Depreciation & Amortization | $22.29M | $21.93M | $20.01M | $14.15M | $7.45M | $4.74M | $3.5M | $650K | $11K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $63.52M | $0 | $11.75M | $500K |
| Stock-Based Compensation | $94.24M | $120.66M | $98.65M | $84.32M | $43.57M | $15.38M | $7.03M | $7M | $198K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $0 | $0 | $300M | -$300M | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | -$300M | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $6.04M | $1.81M | -$7.58M | $2.37M | $818K | $60K | $4.09M | $2.44M | $726K |
| Other Working Capital | -$137.06M | -$112.03M | -$108.88M | $249.25M | $410.44M | $5.29M | -$14.8M | $7.64M | $14K |
| Total Working Capital Change | -$131.02M | -$110.22M | -$116.45M | $251.63M | $111.25M | $5.35M | -$10.71M | $10.07M | $740K |
| Other Non-Cash Items | -$250.63M | -$2.87M | -$18.87M | -$38.48M | $142.09M | $9.87M | $6.5M | $66.96M | $3.85M |
| Net Cash from Operating | -$345.1M | -$347.25M | -$149.19M | $22.53M | -$66.27M | -$95.74M | -$72M | -$20.3M | -$2.71M |
| Investing Activities | |||||||||
| Capital Expenditures | -$14.95M | -$8.95M | -$33.73M | -$48.95M | -$46.81M | -$16.36M | -$12.52M | -$13.12M | -$346K |
| Acquisitions | -$78K | $0 | $0 | $412.38M | $620K | $83.77M | $0 | $0 | $0 |
| Purchases of Investments | -$1.21B | -$486.44M | -$984.34M | -$1.62B | -$777.22M | -$282.36M | -$130.21M | -$300K | $0 |
| Sales of Investments | $848.63M | $680.39M | $1.09B | $1.2B | $529.27M | $198.6M | $76.07M | $0 | $0 |
| Other Investing Activities | $254.75M | $0 | $0 | -$412.38M | $0 | -$83.77M | $0 | -$300K | $0 |
| Net Cash from Investing | -$121.44M | $185.01M | $71.84M | -$461.34M | -$294.14M | -$100.12M | -$66.66M | -$13.42M | -$346K |
| Financing Activities | |||||||||
| Debt Repaid | - | $485K | $2.25M | $2.29M | $2.12M | -$1.7M | -$5.71M | - | - |
| Common Stock Issuance | $478.05M | $8.22M | $270.17M | $108.26M | $757.45M | $319.53M | $0 | $179.73M | $4.98M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $8.53M | $5.62M | $810K | $1.1M | -$2.34M | $10K | $0 |
| Net Cash from Financing | $478.05M | $7.74M | $276.45M | $111.59M | $756.14M | $322.32M | $41.28M | $179.73M | $4.98M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $11.51M | -$154.5M | $199.09M | -$327.22M | $395.73M | $126.46M | -$97.38M | $146M | $1.93M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$345.1M | -$347.25M | -$149.19M | $22.53M | -$66.27M | -$95.74M | -$72M | -$20.3M | -$2.71M |
| Capital Expenditure | -$14.95M | -$8.95M | -$33.73M | -$48.95M | -$46.81M | -$16.36M | -$12.52M | -$13.12M | -$346K |
| Free Cash Flow | -$360.05M | -$356.19M | -$182.93M | -$26.42M | -$113.08M | -$112.1M | -$84.52M | -$33.42M | -$3.05M |
| Cash at Beginning | $290.11M | $444.61M | $245.52M | $572.74M | $177.01M | $50.55M | $147.94M | $1.93M | $0 |
| Cash at End | $301.62M | $290.11M | $444.61M | $245.52M | $572.74M | $177.01M | $50.55M | $147.94M | $1.93M |